These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25122433)

  • 21. Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Duijm M; van der Voort van Zyp NC; van de Vaart P; Oomen-de Hoop E; Mast ME; Hoogeman MS; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):73-81. PubMed ID: 31499137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
    Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
    Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
    Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary hilar stereotactic body radiation therapy in the rat.
    Tinnel B; Mendonca MS; Henderson M; Cummings O; Chin-Sinex H; Timmerman R; McGarry RC
    Technol Cancer Res Treat; 2007 Oct; 6(5):425-31. PubMed ID: 17877431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.
    Videtic GM; Stephans KL; Woody NM; Reddy CA; Zhuang T; Magnelli A; Djemil T
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):203-8. PubMed ID: 25015198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.
    Nuyttens JJ; van der Voort van Zyp NC; Praag J; Aluwini S; van Klaveren RJ; Verhoef C; Pattynama PM; Hoogeman MS
    Radiother Oncol; 2012 Mar; 102(3):383-7. PubMed ID: 22265734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic body radiotherapy for lung tumors at the pulmonary hilum.
    Oshiro Y; Aruga T; Tsuboi K; Marino K; Hara R; Sanayama Y; Itami J
    Strahlenther Onkol; 2010 May; 186(5):274-9. PubMed ID: 20437017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results.
    Shibamoto Y; Hashizume C; Baba F; Ayakawa S; Miyakawa A; Murai T; Takaoka T; Hattori Y; Asai R
    J Thorac Oncol; 2015 Jun; 10(6):960-4. PubMed ID: 26001145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
    Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors.
    Wu AJ; Williams E; Modh A; Foster A; Yorke E; Rimner A; Jackson A
    Radiother Oncol; 2014 Aug; 112(2):267-71. PubMed ID: 25064471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study.
    Nuyttens JJ; van der Voort van Zyp NC; Verhoef C; Maat A; van Klaveren RJ; van der Holt B; Aerts J; Hoogeman M
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):337-43. PubMed ID: 25636758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.
    Forquer JA; Fakiris AJ; Timmerman RD; Lo SS; Perkins SM; McGarry RC; Johnstone PA
    Radiother Oncol; 2009 Dec; 93(3):408-13. PubMed ID: 19454366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidental prophylactic nodal irradiation and patterns of nodal relapse in inoperable early stage NSCLC patients treated with SBRT: a case-matched analysis.
    Lao L; Hope AJ; Maganti M; Brade A; Bezjak A; Saibishkumar EP; Giuliani M; Sun A; Cho BC
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):209-15. PubMed ID: 24997639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.